Laboratory Of America Share Price (NYSE: LH)

$276.53

▲

1.24

(0.45%)

Live

Last updated on August 30, 2025 at 12:39 am IST

$₹

Check the interactive Laboratory Of America Stock chart to analyse performance

Laboratory Of America stock performance

as on August 30, 2025 at 12:39 am IST

Today's Low:$276.34
Today's High:$277.02
$276.53
0.07%
Downside
Day's Volatility :0.25%
Upside
0.18%
52 Weeks Low:$209.38
52 Weeks High:$283.47
$276.53
24.28%
Downside
52 Weeks Volatility :26.14%
Upside
2.45%

Laboratory Of America Stock Returns

Period	Laboratory Corp. Of America Holdings	Sector (Health Care)	Index (Russel 2000)
3 Months	10.57%	3.1%	0.0%
6 Months	9.66%	-8.4%	0.0%
1 Year	19.85%	-12.6%	0.0%
3 Years	20.73%	7.9%	-6.1%

Laboratory Corp. Of America Holdings Key Stats

Check Laboratory Of America key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$275.29
Open	$276.12
Today's High	$277.96
Today's Low	$276.34
Market Capitalization	$23.2B
Today's Volume	$298.5K
52 Week High	$283.47
52 Week Low	$209.375
Revenue TTM	$13.5B
EBITDA	$1.8B
Earnings Per Share (EPS)	$9.08
PE Ratio	30.76
Dividend Yield	1.03%
Profit Margin	5.66%
Quarterly Earnings Growth YOY	0.17%
Return On Equity TTM	9.26%

Stock Returns calculator for Laboratory Of America Stock including INR - Dollar returns

The Laboratory Of America stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Laboratory Of America investment value today

Current value as on today

₹1,25,570

Returns

₹25,570

(+25.57%)

Returns from Laboratory Of America Stock

₹20,393 (+20.39%)

Dollar Returns*

₹5,177 (+5.18%)

Indian investors sentiment towards Laboratory Of America Stock

-45%

Period: Jul 29, 2025 to Aug 28, 2025. Change in 30 Days versus previous period

Search interest for Laboratory Of America Stock from India on INDmoney has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Laboratory Of America Stock

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	677	1.35	0.04%

Global Institutional Holdings in Laboratory Corp. Of America Holdings

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
11.89%
BlackRock Inc
11.16%
State Street Corp
4.61%
Select Equity Group LP
2.57%
Geode Capital Management, LLC
2.49%
Allspring Global Investments Holdings, LLC
2.36%

Analyst Recommendation on Laboratory Of America Stock

Rating

Trend

Buy

76%Buy

23%Hold

0%Sell

Based on 26 Wall street analysts offering stock ratings for Laboratory Of America(by analysts ranked 0 to 5 stars)

Laboratory Of America Share Price Target

What analysts predicted

Upside of 6.23%

Target:

$293.76

Current:

$276.53

Laboratory Of America share price target is $293.76, a slight Upside of 6.23% compared to current price of $276.53 as per analysts' prediction.

Laboratory Of America Stock Insights

Price Movement
In the last 1 year, LH stock has moved up by 19.8%
Increasing Revenue
Revenue is up for the last 7 quarters, 3.03B → 3.52B (in $), with an average increase of 2.5% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 143.4M → 237.9M (in $), with an average increase of 21.6% per quarter
LH vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 32.4% return, outperforming this stock by 12.6%
LH vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 84.8% return, outperforming this stock by 64.9%
Price to Sales
ForLH every $1 of sales, investors are willing to pay $1.7, whereas for Idexx Laboratories, Inc., the investors are paying $13.0 for every $1 of sales.

Laboratory Corp. Of America Holdings Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$11.6B	↑ 1.95%
Net Income	$823.8M	↓ 6.78%
Net Profit Margin	7.13%	↓ 0.67%

	FY20	Y/Y Change
Revenue	$14.0B	↑ 20.98%
Net Income	$1.6B	↑ 88.89%
Net Profit Margin	11.13%	↑ 4.0%

	FY21	Y/Y Change
Revenue	$13.1B	↓ 6.03%
Net Income	$2.4B	↑ 52.77%
Net Profit Margin	18.1%	↑ 6.97%

	FY22	Y/Y Change
Revenue	$11.9B	↓ 9.68%
Net Income	$1.3B	↓ 46.2%
Net Profit Margin	10.78%	↓ 7.32%

	FY23	Y/Y Change
Revenue	$12.2B	↑ 2.51%
Net Income	$418.0M	↓ 67.32%
Net Profit Margin	3.44%	↓ 7.34%

	FY24	Y/Y Change
Revenue	$13.0B	↑ 6.97%
Net Income	$746.0M	↑ 78.47%
Net Profit Margin	5.73%	↑ 2.29%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$3.2B	↑ 4.72%
Net Income	$228.0M	↓ 236.45%
Net Profit Margin	7.18%	↑ 12.69%

	Q2 FY24	Q/Q Change
Revenue	$3.2B	↑ 1.39%
Net Income	$205.3M	↓ 9.96%
Net Profit Margin	6.37%	↓ 0.81%

	Q3 FY24	Q/Q Change
Revenue	$3.3B	↑ 1.9%
Net Income	$169.3M	↓ 17.54%
Net Profit Margin	5.16%	↓ 1.21%

	Q4 FY24	Q/Q Change
Revenue	$3.3B	↑ 1.44%
Net Income	$143.4M	↓ 15.3%
Net Profit Margin	4.31%	↓ 0.85%

	Q1 FY25	Q/Q Change
Revenue	$3.3B	↑ 0.47%
Net Income	$212.8M	↑ 48.4%
Net Profit Margin	6.36%	↑ 2.05%

	Q2 FY25	Q/Q Change
Revenue	$3.5B	↑ 5.45%
Net Income	$237.9M	↑ 11.8%
Net Profit Margin	6.74%	↑ 0.38%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$3.3B	↑ 2.4%

	FY20	Y/Y Change
Profit	$5.0B	↑ 52.28%

	FY21	Y/Y Change
Profit	$5.0B	↑ 0.8%

	FY22	Y/Y Change
Profit	$3.7B	↓ 25.71%

	FY23	Y/Y Change
Profit	$3.4B	↓ 9.27%

	FY24	Y/Y Change
Profit	$3.6B	↑ 7.71%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$897.3M	↑ 17.73%

	Q2 FY24	Q/Q Change
Profit	$926.4M	↑ 3.24%

	Q3 FY24	Q/Q Change
Profit	$904.4M	↓ 2.37%

	Q4 FY24	Q/Q Change
Profit	$896.3M	↓ 0.9%

	Q1 FY25	Q/Q Change
Profit	$948.0M	↑ 5.77%

	Q2 FY25	Q/Q Change
Profit	$1.0B	↑ 10.36%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$1.4B	↑ 10.67%
Investing Cash Flow	$-1.3B	↓ 720.75%
Financing Cash Flow	$-252.7M	↓ 81.82%

	FY20	Y/Y Change
Operating Cash Flow	$2.1B	↑ 47.8%
Investing Cash Flow	$-643.2M	↓ 49.87%
Financing Cash Flow	$-517.4M	↑ 104.75%

	FY21	Y/Y Change
Operating Cash Flow	$3.1B	↑ 45.63%
Investing Cash Flow	$-884.6M	↑ 37.53%
Financing Cash Flow	$-2.1B	↑ 299.27%

	FY22	Y/Y Change
Operating Cash Flow	$2.0B	↓ 37.1%
Investing Cash Flow	$-1.7B	↑ 86.77%
Financing Cash Flow	$-1.3B	↓ 36.0%

	FY23	Y/Y Change
Operating Cash Flow	$1.3B	↓ 32.12%
Investing Cash Flow	$-1.2B	↓ 29.09%
Financing Cash Flow	$-59.3M	↓ 95.52%

	FY24	Y/Y Change
Operating Cash Flow	$1.6B	↑ 19.44%
Investing Cash Flow	$-1.4B	↑ 16.67%
Financing Cash Flow	$779.9M	↓ 1415.18%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-29.8M	↓ 105.14%
Investing Cash Flow	$-393.1M	↑ 18.91%
Financing Cash Flow	$-11.7M	↓ 97.38%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$561.1M	↓ 1982.89%
Investing Cash Flow	$-185.0M	↓ 52.94%
Financing Cash Flow	$-210.0M	↑ 1694.87%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$277.3M	↓ 50.58%
Investing Cash Flow	$-579.1M	↑ 213.03%
Financing Cash Flow	$1.5B	↓ 837.29%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$777.2M	↑ 180.27%
Investing Cash Flow	$-209.6M	↓ 63.81%
Financing Cash Flow	$-546.7M	↓ 135.31%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$18.5M	↓ 97.62%
Investing Cash Flow	$-336.0M	↑ 60.31%
Financing Cash Flow	$-839.7M	↑ 53.59%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$620.6M	↑ 3254.59%
Investing Cash Flow	$-94.1M	↓ 71.99%
Financing Cash Flow	$-267.4M	↓ 68.16%

Laboratory Of America Technicals Summary

Sell

Neutral

Buy

Laboratory Of America is currently in a neutral trading position according to technical analysis indicators.

Laboratory Corp. Of America Holdings Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Laboratory Corp. Of America Holdings	4.31%	9.66%	19.85%	20.73%	56.63%
Agilent Technologies Inc.	5.89%	-2.28%	-12.3%	-2.56%	24.48%
Idexx Laboratories, Inc.	12.77%	47.59%	32.39%	84.93%	64.97%
Thermo Fisher Scientific, Inc.	2.7%	-7.33%	-19.86%	-11.57%	14.27%
Danaher Corp.	0.62%	-1.21%	-23.13%	-24.92%	-0.59%
Iqvia Holdings Inc.	-1.47%	-0.04%	-24.75%	-12.62%	15.25%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Laboratory Corp. Of America Holdings	30.76	30.76	1.03	16.32	0.09	0.04	0.01	102.2
Agilent Technologies Inc.	29.13	29.13	1.74	5.57	0.19	0.08	0.0	20.68
Idexx Laboratories, Inc.	53.18	53.18	4.8	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.25	28.25	1.99	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	43.43	43.43	2.05	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	27.39	27.39	1.08	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Laboratory Corp. Of America Holdings	Buy	$23.2B	56.63%	30.76	5.66%
Agilent Technologies Inc.	Buy	$35.5B	24.48%	29.13	17.59%
Idexx Laboratories, Inc.	Buy	$51.3B	64.97%	53.18	24.41%
Thermo Fisher Scientific, Inc.	Buy	$184.3B	14.27%	28.25	15.24%
Danaher Corp.	Buy	$146.8B	-0.59%	43.43	14.21%
Iqvia Holdings Inc.	Buy	$32.1B	15.25%	27.39	7.88%

Laboratory Of America Dividend announcements

Laboratory Of America Dividends September, 2025
In the quarter ending September,2025. Laboratory Of America has declared dividend of $0.72

About Laboratory Corp. Of America Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governments, physician, large provider organizations, other healthcare providers, hospitals and health systems, patients and consumers, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.

Organization	Laboratory Of America
Employees	70000
CEO	Mr. Adam H. Schechter
Industry	Health Services

Key Management of Laboratory Corp. Of America Holdings

Name	Title
Mr. Adam H. Schechter	President, CEO & Chairman
Ms. Julia A. Wang	CFO & Executive VP
Mr. Mark S. Schroeder	Executive VP, President of Diagnostics Laboratories & COO
Dr. Brian J. Caveney J.D., M.D., M.P.H.	EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer
Ms. Anita Z. Graham	Executive VP & Chief Human Resources Officer
Mr. Peter J. Wilkinson	Senior VP & Chief Accounting Officer
Mr. Akinbolade Oyegunwa M.B.A., Ph.D.	Executive VP and Chief Information & Technology Officer
Christin O'Donnell	Vice President of Investor Relations
Ms. Sandra D. van der Vaart J.D.	Executive VP, Chief Legal Officer & Corporate Secretary
Ms. Amy B. Summy	EVP, Chief Marketing Officer & Consumer Business Lead

Important FAQs about investing in LH Stock from India :

What is Laboratory Of America share price today?

Laboratory Of America share price today is $276.53 as on August 30, 2025 at 12:39 am IST. Laboratory Of America share today touched a day high of $277.02 and a low of $276.34.

What is the 52 week high and 52 week low for Laboratory Of America share?

Laboratory Of America share touched a 52 week high of $283.47 and a 52 week low of $209.38. Laboratory Of America stock price today i.e. August 30, 2025 at 12:39 am IST is trending at $276.53, lower by 2.45% versus the 52 week high.

How to invest in Laboratory Of America Stock (LH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Laboratory Of America on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Laboratory Of America Shares that will get you 0.0054 shares as per Laboratory Of America share price of $276.53 per share as on August 30, 2025 at 12:39 am IST.

What is the minimum amount required to buy Laboratory Of America Stock (LH) from India?

Indian investors can start investing in Laboratory Of America (LH) shares with as little as ₹88.167 or $1 (as of August 29, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.67 in Laboratory Of America stock (as per the Rupee-Dollar exchange rate as on August 29, 2025). Based on Laboratory Of America share’s latest price of $276.53 as on August 30, 2025 at 12:39 am IST, you will get 0.0362 shares of Laboratory Of America. Learn more about fractional shares .

What are the returns that Laboratory Of America has given to Indian investors in the last 5 years?

Laboratory Of America stock has given 56.63% share price returns and 20.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?